Embed this press release by copying the code below:
MAP Pharmaceuticals Inc. (NASDAQ:MAPP) Investor Investigation over Potential Misleading Statements
MAP Pharmaceuticals Inc. (NASDAQ:MAPP) Investor Investigation over Potential Misleading Statements